Brief: Cumberland Pharmaceuticals Q3 Adjusted Loss Per Share $0.05
13/11/2018 21:22
Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS
* Q3 ADJUSTED LOSS PER SHARE $0.05
* Q3 REVENUE $8.5 MILLION VERSUS $11.2 MILLION
* Q3 LOSS PER SHARE $0.11
Source text for Eikon: ID:nPn8SsHXsa
Further company coverage: CPIX.O
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM